Featured Medical Webinars
Join Bruker Arxspan to explore solutions and new technologies available to answer all your molecular
AI in the healthcare space has seen tremendous growth in recent years. As a result of this growth, it has encouraged new development for both hardware and software to allow AI capabilities. Join this new webinar titled, How AI is Advancing Next Generation Medical Imaging Devices and discover more.
mRNA vaccine methodologies have many advantages over traditional vaccine workflows.
Selecting an adhesive for a medical device application can be challenging. Learn how to navigate the selection process.
In this webinar, we will dive into DSC testing and analysis of pharmaceutical materials to better understand how to obtain accurate results and avoid potential problems with data interpretation.
Having comprehensive documentation of chemical analyses is crucial for any pharma QC lab. Capturing the entire analytical process requires the right data management solution.
In this webinar we build on the points discussed in 2016 using recently published data to learn how emergency physicians can use point-of-care (POC) biochemical analyzers to improve safety and efficiency in the Emergency Department (ED).
Not all hemoglobin measurement methods provide quality results. Choosing the incorrect device and not understanding performance limits can result in unnecessary blood utilization and excess cost.
This webinar will review all steps in the preanalytical phase of blood gas testing focusing on all possible sources or errors and error prevention opportunities. A specific emphasis is centered around the area of “mixing a blood gas sample” in order to obtain a homogeneous blood sample.
Sample collection issues are the most common cause of inaccurate laboratory results. Those inaccurate results can impact patient care, waste valuable time and lead to unnecessary costs.
The content aims to analyze the value contributed by the diagnosis and prognosis with procalcitonin in symptoms of sepsis, and its usefulness in the therapy to be applied to the patient in comparison with other methods, such as blood culture or CRP.
This webinar is produced by Whitehat Communications and sponsored by Radiometer and acutecaretesting.org. It is an updated version of the session originally presented in October 2016.
An integral part of many screening protocols for emergency admissions is the assessment of kidney function. By determining, among other things, creatinine levels and the eGFR, patients with acute renal failure (ANV) can be identified quickly.
Continuous measurement of oxygenation and ventilation status detects sudden changes in the respiratory status in the fragile neonate. Premature and critically ill babies in the NICU are fragile and at risk of sudden changes in oxygenation (pO2) and carbon dioxide (pCO2) levels which can cause severe complications.
The facts speak for themselves - Sepsis is one of the most common diseases worldwide and the leading cause of death in infectious diseases with a mortality of 30 to 60 percent - often because it is not detected early enough.
D-dimer can be used to exclude venous thromboembolism (VTE) in outpatients. Together with a low pretest probability for VTE, a negative D-dimer can safely rule out VTE in 30-50 % of patients with suspected VTE.
Sepsis threatens the lives of over 27 million people each year worldwide. Inappropriate or delayed treatment allows for disease progression to severe sepsis, septic shock and ultimately to 8 million deaths per year.
In this webinar a current update of airway management assessment and techniques will be given and the emerging role of transcutaneous CO2 monitoring in the operating theatre will be discussed.
Blood conservation is a major objective for health care providers today. An unnecessary blood transfusion can pose potential risk to the patient and be costly. Decisions to give the patient blood are commonly made with POC devices that measure total hemoglobin directly or indirectly.
The main role of emergency medicine is to diagnose and treat acute medical conditions. Paramount is the rapid identification of critical illness. The key diagnostic tools at our disposal are history, examination, imaging and blood tests.
Preanalytical errors are said to be the reason for up to 62% of all errors in laboratory medicine. Seven percent of percutaneous needle stick injuries are reported to occur in intensive and cardiac care units and operating rooms.
Within the field of in vitro diagnostics, the area of Point-of-Care Testing (POCT) has been one of those that have evolved most significantly, being more and more frequent its presence in certain clinical services as a tool for the management of the critical patient.
The January 1st deadline for completion of your hospital's IQCP is coming fast, along with a host of questions from those responsible for creating their plans. If IQCP is optional, what are the alternatives? Is an IQCP plan needed for every blood gas analyzer?
The survival rate of critically ill newborns has increased during the last few decades, especially for extremely preterm infants. However, overall morbidity in surviving newborns is still high in many centers.
In the management of critically ill neonates, measurement of arterial oxygenation is frequently required to prevent hypoxia or hyperoxia. Hypoxia may lead to pulmonary vasoconstriction and pulmonary hypertension. In addition, the resulting alterations in systemic blood flow may lead to neurologic and other organ damage.
The process of birth is the most dangerous journey any individual undertakes. The risk of the fetus being “asphyxiated during labor” - that is to encounter insufficient oxygen supply - is a substantial concern even in labor wards in high income countries.
Traditionally, sleep centers performed overnight polysomnography primarily for the management of obstructive sleep apnea (OSA) which would typically comprise 90% of studies. As home sleep apnea testing use has been increasing and becoming the primary modality for diagnosing OSA, the nature of polysomnography is evolving as it emphasizes the evaluation of patients with complex diseases.
Venous blood sampling is the most common invasive procedure in healthcare. A recent investigation performed by the Working group for Preanalytical Phase (WG-PRE) of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) has shown that blood sampling in Europe is performed by different professions with significantly different levels of education, background, competence and skills.
The specimen of choice that enables the collection of small blood volumes from neonatal or critically ill patients is a capillary blood specimen. This specimen type has gained favour with many physicians for the analysis of blood gases, electrolytes and/or metabolites like glucose, lactate, creatinine or total bilirubin.
Care of critically ill newborn patients requires regular measurement of arterial oxygenation levels to avoid or limit the risk of hypoxia or hyperoxia.
Diabetic foot ulcers represent a common indication for hyperbaric oxygen (HBO) therapy. Broad acceptance currently exists by those in a position to refer such patients as well as by those who purchase health care. Despite this, its use has recently been called into question.
There is an increasing awareness of the impact of errors in medicine on the patient and on the entire healthcare system. It is estimated that as many as 98,000 people die annually in the USA as a result of preventable medical errors. This problem has been recognized by both World Health Organization (WHO) as well as by the European Commission (EC).
Patients with suspected acute coronary syndrome (ACS) make up roughly 10% of Emergency Department (ED) presentations. Approximately 80-90% of these patients are eventually diagnosed with a non-cardiac cause following assessment.
There is an increasing awareness of the impact of errors in medicine on the patient and on the entire healthcare system. It is estimated that as many as 98,000 people die annually in the USA as a result of preventable medical errors.
The care of the neonate has been a continuous evolving art. In the 1970s and '80s, we had limited continuous monitoring of both oxygen and carbon dioxide.
Session 2 will provide a more in-depth look at the ability of today’s blood gas testing to determine the cause of reduced oxygen transport and release to tissues.
Evaluation of a patient’s respiratory and ventilatory status is often based on intermittent arterial samples that are neither practical during sleep nor offer continuous blood gas monitoring. End-tidal CO2 (ETCO2) monitoring is used to indicate patient ventilation status as it reflects trends of arterial pCO2 (PaCO2).
Heart failure is the fastest rising diagnostic condition in modern cardiology today. In the US alone, approximately one million new patients are diagnosed with heart failure each year.
Natriuretic peptides are secreted from the heart as counter regulatory hormones in response to increased intraventricular and atrial pressure and stretch.
All clinicians understand that disasters are more likely to be averted when trends are detected early. This is especially true when caring for the varied cross-section of patients who hypo/hyperventilate.
Blood gas testing has improved over the years thanks to advances in technology. 60 years ago, blood gas testing meant determining pO2, pCo2 and pH levels.